Latest News and Press Releases

WASHINGTON, May 13, 2025 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute today awarded the Albert B. Sabin Gold Medal to pediatrician Katherine O’Brien, MD, MPH, for her research on the pneumococcal...

GVN calls on world governments to address the threat of H5N1 avian influenza by enhancing surveillance, implementing biosecurity measures, and preparing

Washington, DC, April 18, 2025 (GLOBE NEWSWIRE) -- ThinkCareBelieve's Week 13 Article: https://thinkcarebelieve.blog/2025/04/18/week-13-under-president-trumps-leadership/ Article on Release of...

JUPITER, Fla., April 16, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (Nasdaq: DYAI), a biotechnology company that utilizes its microbial...

Washington, DC, April 11, 2025 (GLOBE NEWSWIRE) -- Link to Article:  https://thinkcarebelieve.blog/2025/04/11/week-12-of-trumps-america/ ThinkCareBelieve has published an article covering a...

$171.4 million of cash, cash equivalents and marketable securities as of December 31, 2024 The company is exploring the potential for continued development of its norovirus vaccine candidates in...

Curevo Vaccine closes a $110 million Series B round led by Medicxi, with new investors OrbiMed, HBM Healthcare Investments, and Sanofi Ventures.

Vaccine is intended to stimulate T cell responses against targets across the entire genome of the selected virus, similar to company’s lead product candidate TVGN 489, to mitigate the risk posed by...

The GVN urgently recommends the measles-mumps-rubella (MMR) vaccine for unvaccinated children and adults to prevent avoidable and unnecessary health crises

VAXXITEK® HVT+IBD+H5 is a new trivalent vaccine for poultry that offers protection against Marek’s disease, Infectious Bursal Disease and H5 avian influenza in just one shot.   H5 avian influenza...